<code id='03A24EA643'></code><style id='03A24EA643'></style>
    • <acronym id='03A24EA643'></acronym>
      <center id='03A24EA643'><center id='03A24EA643'><tfoot id='03A24EA643'></tfoot></center><abbr id='03A24EA643'><dir id='03A24EA643'><tfoot id='03A24EA643'></tfoot><noframes id='03A24EA643'>

    • <optgroup id='03A24EA643'><strike id='03A24EA643'><sup id='03A24EA643'></sup></strike><code id='03A24EA643'></code></optgroup>
        1. <b id='03A24EA643'><label id='03A24EA643'><select id='03A24EA643'><dt id='03A24EA643'><span id='03A24EA643'></span></dt></select></label></b><u id='03A24EA643'></u>
          <i id='03A24EA643'><strike id='03A24EA643'><tt id='03A24EA643'><pre id='03A24EA643'></pre></tt></strike></i>

          entertainment

          entertainment

          author:knowledge    Page View:65751
          Two Vertex buidings in the Seaport District
          David L Ryan/Globe Staff

          When Vertex Pharmaceuticals moved from Cambridge to Boston’s Seaport a decade ago, it signaled that what was then a sea of parking lots could be a booming business district, and galvanized a wave of new development.

          Now, Vertex may be on the move again.

          advertisement

          With the lease on its two-building campus on Fan Pier set to expire in 2028, the company is reevaluating its real estate options — and considering leaving its prominent headquarters for another spot in the neighborhood.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          leisure time

          Anesthesiologist group: stop taking Ozempic before surgery
          Anesthesiologist group: stop taking Ozempic before surgery

          EspeciallyinthefirstweeksoftakingdrugslikeOzempic,foodstayslongerinthestomach—aprobleminsurgeries.Ad

          read more
          Ultragenyx gene therapy for rare liver ailment succeeds in late
          Ultragenyx gene therapy for rare liver ailment succeeds in late

          JonathanWiggs/GlobeStaffUltragenyxsaidThursdayafternoonthatitsgenetherapyforarareliverailment,glycog

          read more
          As demand for Covid shots wanes, Moderna seeks its next success
          As demand for Covid shots wanes, Moderna seeks its next success

          RubyWallauforSTATModernachairmanNoubarAfeyanexudedstarpowerearlierthismonthashecommandedthespotlight

          read more

          Innovation in antibiotics is ailing. 'Brain drain' may kill it

          Asantibioticsresearchshrivels,thebraindrainawayfromthisfieldwillhavemanylabslookingthisempty.AdobeIn